San Francisco, California 94143


Purpose:

Hypertension is an increasingly common problem in children, especially among those who are obese or with diabetes and chronic kidney disease. This study is a pilot randomized controlled trial designed to test whether improved blood pressure control can be achieved with the use of remote home blood pressure monitoring in children with uncontrolled blood pressure.


Study summary:

Hypertension is an increasingly common problem in children, especially among those who are obese or with diabetes and chronic kidney disease. This study is a pilot randomized controlled trial designed to test whether improved blood pressure control can be achieved with the use of remote home blood pressure monitoring in children with uncontrolled blood pressure. We will randomize 60 children who have elevated BP (defined as receipt of ≥1 anti-hypertensive agent or office SBP ≥90th percentile) to either home BP monitoring with a home SBP target of < 90th percentile or less than 120 mm Hg, which ever is lower (intervention group) versus usual care group in 2:1 ratio. This study aims to (1) compare the safety of BP lowering in intervention versus usual care patients, (2) determine the efficacy of the intervention and provide estimates for the refinement of sample size determination for our eventual full-scale trial, and (3) assess the feasibility and acceptability of the intervention, recruitment rates, and barriers to trial completion.


Criteria:

Inclusion Criteria: - must be receiving at least one anti-hypertensive agent or have an office SBP ≥120 mmHg or >90th percentile for age, sex or height at the time of the screening visit - have a mid-arm circumference between 22-37cm (BP cuff size limitation) - able to provide consent to participate in our study - able to use smartphones, or able to use any phone to call or text our study personnel with home BP readings. If participant does not have a smartphone, they will be allowed to call, text, or e-mail home BP readings on a weekly basis instead. Exclusion Criteria: We will exclude those who: - are or are planning to become pregnant, due to inability to take multiple classes of anti-hypertensive agents - are marginally housed, due to concerns regarding routine follow-up - are actively participating in a different interventional trial that may affect blood pressure - are unwilling to consent to participate - institutionalized individuals or prisoners - are actively abusing illicit drugs or alcohol - have a history of poor or doubtful compliance (e.g., frequently missed appointments) - have office SBP >170 mmHg - are already taking ≥5 anti-hypertensive medications (any classes, including diuretics) - have cognitive impairment prohibiting participation in the study


NCT ID:

NCT03691701


Primary Contact:

Principal Investigator
Elaine Ku, MD
University of California, San Francisco

Elaine Ku, MD
Phone: 415-353-2507
Email: Elaine.Ku@ucsf.edu


Backup Contact:

Email: seri.bae@ucsf.edu
Se Ri Bae, BA
Phone: 415-917-3233


Location Contact:

San Francisco, California 94143
United States

Se Ri Bae, BA
Phone: 415-917-3233
Email: seri.bae@ucsf.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.